Begin main content

Events Archives

CADTH Lecture Series – Gene Therapy

February 27, 2018
The CADTH Lecture Series provides prominent scholars and opinion leaders with a forum to discuss pressing issues facing health technology assessment (HTA) and health care today. Dr. Matthew Seftel, MBChB, MPH, FRCP, FRCPC Head, Department of Medical Oncology and Hematology, CancerCare Manitoba Associate Professor, Section of Hematology/Oncology,...

Doing the Right Thing... Right: Evidence Informing Clinical Decision-Making

February 22, 2018
The Institute Health Economics (IHE), the Canadian Agency for Drugs & Technologies in Health (CADTH) and Alberta Health are pleased to present “Doing the Right Thing... Right: Evidence Informing Clinical Decision-Making.” Dr. Brian O’Rourke, President and Chief Executive Officer, CADTH, will be a keynote presenter at this forum, along with D...

Compliant Flooring to Prevent Fall-Related Injuries: A Scoping Review

February 1, 2018
Compliant flooring is designed to reduce the incidence and severity of fall-related injuries, including hip fractures and traumatic brain injuries. This webinar will present the key findings and recommendations of a scoping review that synthesized the evidence in four areas: biomechanical efficacy clinical effectiveness cost-effectiveness workpl...

Biologics and Biosimilars

November 23, 2017
Lisa Farrell, CADTH Liaison Officer, Nova Scotia, hosted an online overview session on biosimilars with the Canadian Hospital Pharmacists Association (CHPA). They discussed what biosimilars are, and how the regulatory, health technology assessment, and reimbursement pathway differs for them from other products Marina Richardson, MSc, Clinical Re...